SI1286668T1 - Pharmaceutical combinations comprising tegaserod und omeprazole and their use in treating gastrointestinal disorders - Google Patents
Pharmaceutical combinations comprising tegaserod und omeprazole and their use in treating gastrointestinal disordersInfo
- Publication number
- SI1286668T1 SI1286668T1 SI200030702T SI200030702T SI1286668T1 SI 1286668 T1 SI1286668 T1 SI 1286668T1 SI 200030702 T SI200030702 T SI 200030702T SI 200030702 T SI200030702 T SI 200030702T SI 1286668 T1 SI1286668 T1 SI 1286668T1
- Authority
- SI
- Slovenia
- Prior art keywords
- tegaserod
- omeprazole
- und
- gastrointestinal disorders
- pharmaceutical combinations
- Prior art date
Links
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 title 1
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- 229960000381 omeprazole Drugs 0.000 title 1
- IKBKZGMPCYNSLU-RGVLZGJSSA-N tegaserod Chemical compound C1=C(OC)C=C2C(/C=N/NC(=N)NCCCCC)=CNC2=C1 IKBKZGMPCYNSLU-RGVLZGJSSA-N 0.000 title 1
- 229960002876 tegaserod Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45838899A | 1999-12-10 | 1999-12-10 | |
| EP00989967A EP1286668B1 (en) | 1999-12-10 | 2000-12-08 | Pharmaceutical combinations comprising tegaserod und omeprazole and their use in treating gastrointestinal disorders |
| PCT/EP2000/012420 WO2001041748A2 (en) | 1999-12-10 | 2000-12-08 | Pharmaceutical combinations and their use in treating gastrointestinal disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1286668T1 true SI1286668T1 (en) | 2005-10-31 |
Family
ID=33420395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200030702T SI1286668T1 (en) | 1999-12-10 | 2000-12-08 | Pharmaceutical combinations comprising tegaserod und omeprazole and their use in treating gastrointestinal disorders |
Country Status (1)
| Country | Link |
|---|---|
| SI (1) | SI1286668T1 (en) |
-
2000
- 2000-12-08 SI SI200030702T patent/SI1286668T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301122A3 (en) | Pharmaceutical combinations and their use in treating gastrointestinal disorders | |
| AU5714601A (en) | Methods for prevention and treatment of gastrointestinal disorders | |
| IL151946A0 (en) | 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders | |
| IL144508A0 (en) | Compositions and methods for use in targeting vascular destruction | |
| EP0924983A4 (en) | S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders | |
| HUP0203588A3 (en) | Analgesic pharmaceutical compositions and their use | |
| IL144954A0 (en) | Quinazolines and therapeutic use thereof | |
| AU2003291609A1 (en) | Cb 1/cb 2 receptor ligands and their use in the treatment of pain | |
| HUP0400069A3 (en) | Pharmaceutical combinations and their use in preventing and treating the thrombosis | |
| GB0004167D0 (en) | 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents | |
| AP2002002393A0 (en) | Naphthoquinone derivatives and their use in the treatment and control of tuberculosis | |
| ZA97741B (en) | Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders. | |
| AU2002243363A8 (en) | Use of aziridino-compounds in the treatment of immune dysfunctions | |
| IL150289A0 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine | |
| CZ20021489A3 (en) | N-guanidinoalkylamides, process of their preparation, use and pharmaceutical mixtures in which they are comprised | |
| PL352333A1 (en) | Dihydrobenzodiazepines and use of same in treatment of dislipidemia | |
| HUP0301553A3 (en) | Pharmaceutical compositions and their use for treating neurological disorders | |
| HUP0201966A3 (en) | Methods of treatment and drug screening methods | |
| DE60003550D1 (en) | SUBSTITUTED 3-PYRIDYL-4-ARYLPYRROLE AND THE USE THEREOF IN METHODS FOR THERAPEUTIC AND PROPHYLACTIC TREATMENT | |
| IL130968A0 (en) | Pharmaceutical composition useful for the treatment of tinnitus and hearing loss | |
| PL363048A1 (en) | Azabicyclic derivatives and their therapeutic use | |
| HUP0202339A3 (en) | Use of cortisol antagonists in the treatment of heat failure | |
| IL129460A0 (en) | Use of lofexidine in the treatment of behavioral disorders | |
| SI1286668T1 (en) | Pharmaceutical combinations comprising tegaserod und omeprazole and their use in treating gastrointestinal disorders | |
| IL147410A0 (en) | L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases |